|
1
|
Zhang Y, Gan J, Pu Z, Xu Mm, Wang Lf, Li
Yh and Liu Zg: TSC1 R509X Mutation in a chinese family with
tuberous sclerosis complex. Neuromolecular Med. 17:202–208. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cabrera-López C, Bullich G, Marti T,
Català V, Ballarín J, Bissler JJ, Harris PC, Ars E and Torra R:
Insight into response to mTOR inhibition when PKD1 and TSC2 are
mutated. BMC Med Genet. 16:392015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hallett L, Foster T, Liu Z, Blieden M and
Valentim J: Burden of disease and unmet needs in tuberous sclerosis
complex with neurological manifestations: Systematic review. Curr
Med Res Opin. 27:1571–1583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hyman MH and Whittemore VH: National
Institutes of Health consensus conference: Tuberous sclerosis
complex. Arch Neurol. 57:662–665. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rabito MJ and Kaye AD: Tuberous sclerosis
complex: Perioperative considerations. Ochsner J. 14:229–239.
2014.PubMed/NCBI
|
|
6
|
Wang GX, Wang DW, Yi CY, Qu JS and Wang
YL: Mutational analyses of the TSC1 and TSC2 genes in cases of
tuberous sclerosis complex in Chinese Han children. Genet Mol Res.
12:1168–1175. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Northrup H and Krueger DA: International
Tuberous Sclerosis Complex Consensus Group: Tuberous sclerosis
complex diagnostic criteria update: Recommendations of the 2012
iinternational tuberous sclerosis complex consensus conference.
Pediatr Neurol. 49:243–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sancak O, Nellist M, Goedbloed M,
Elfferich P, Wouters C, Maat-Kievit A, Zonnenberg B, Verhoef S,
Halley D and van den Ouweland A: Mutational analysis of the TSC1
and TSC2 genes in a diagnostic setting: Genotype-phenotype
correlations and comparison of diagnostic DNA techniques in
tuberous sclerosis complex. Eur J Hum Genet. 13:731–741. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Slegtenhorst M, de Hoogt R, Hermans C,
Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A,
Halley D, Young J, et al: Identification of the tuberous sclerosis
gene TSC1 on chromosome 9q34. Science. 277:805–808. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Habib SL: Tuberous sclerosis complex and
DNA repair. Adv Exp Med Biol. 685:84–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Inoki K, Corradetti MN and Guan K L:
Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet.
37:19–24. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Henske EP, Rasooly R, Siroky B and Bissler
J: Tuberous sclerosis complex, mTOR, and the kidney: Report of an
NIDDK-sponsored workshop. Am J Physiol Renal Physiol.
306:F279–F283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yi L, Guo F and Zhang YB: Diagnosis and
analysis of cases of tuberous sclerosis. J Clin Exp Med.
10:819–822. 2015.(In Chinese).
|
|
14
|
Krummel T, Garnon J, Lang H, Gangi A and
Hannedouche T: Percutaneous cryoablation for tuberous
sclerosis-associated renal angiomyolipoma with neoadjuvant mTOR
inhibition. BMC Urol. 14:772014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Curatolo P and Moavero R: mTOR inhibitors
in tuberous sclerosis complex. Curr Neuropharmacol. 10:404–415.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Staehler M, Sauter M, Helck A, Linsenmaier
U, Weber L, Mayer K and Fischereder M: Nephron-sparing resection of
angiomyolipoma after sirolimus pretreatment in patients with
tuberous sclerosis. Int Urol Nephrol. 44:1657–1661. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sasongko TH, Ismail NF and Zabidi-Hussin
Z: Rapamycin and rapalogs for tuberous sclerosis complex. Cochrane
Database Syst Rev. 7:CD0112722016.PubMed/NCBI
|
|
18
|
Peces R, Cuestalópez E, Peces C and Selgas
R: Giant bilateral renal angiomyolipomas and
lymphangioleiomyomatosis presenting after two successive
pregnancies successfully treated with surgery and rapamycin.
ScientificWorldJournal. 11:2115–2123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hallett L, Foster T, Liu Z, Blieden M and
Valentim J: Burden of disease and unmet needs in tuberous sclerosis
complex with neurological manifestations: Systematic review. Curr
Med Res Opin. 27:1571–1583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Crino PB, Nathanson KL and Henske EP: The
tuberous sclerosis complex. N Engl J Med. 355:1345–1356. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Callaghan FJ, Noakes MJ, Martyn CN and
Osborne JP: An epidemiological study of renal pathology in tuberous
sclerosis complex. BJU Int. 94:853–857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mascarenhas R and McLaughlin P:
Haemorrhage from angiomyolipoma of kidney during pregnancy-a
diagnostic dilemma. Ir Med J. 94:83–84. 2001.PubMed/NCBI
|
|
23
|
Raft J, Lalot JM, Meistelman C and
Longrois D: Influence of pregnancy on renal angiomyolipoma. Gynecol
Obstet Fertil. 33:898–906. 2005.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boorjian SA, Sheinin Y, Crispen PL, Lohse
CM, Kwon ED and Leibovich BC: Hormone receptor expression in renal
angiomyolipoma: Clinicopathologic correlation. Urology. 72:927–932.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bissler JJ, Kingswood JC, Radzikowska E,
Zonnenberg BA, Frost M, Belousova E, Sauter M, Nonomura N,
Brakemeier S, de Vries PJ, et al: Everolimus for angiomyolipoma
associated with tuberous sclerosis complex or sporadic
lymphangioleiomyomatosis (EXIST-2): A multicentre, randomised,
double-blind, placebo-controlled trial. Lancet. 381:817–824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Franz DN: Everolimus in the treatment of
subependymal giant cell astrocytomas, angiomyolipomas, and
pulmonary and skin lesions associated with tuberous sclerosis
complex. Biologics. 7:211–221. 2013.PubMed/NCBI
|
|
27
|
Roa J, Garcia-Galiano D, Castellano JM,
Gaytan F, Pinilla L and Tena-Sempere M: Metabolic control of
puberty onset: New players, new mechanisms. Mol Cell Endocrinol.
324:87–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sauter M, Sigl J, Schotten KJ, Kreuzer L,
Günthner-Biller M and Fischereder M: Use of oestrogen-containing
medication is not associated with renal angiomyolipoma in tuberous
sclerosis: Findings from a survey. Int Urol Nephrol. 47:707–708.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang KH, Huang CY, Chung SD, Pu YS, Shun
CT and Chen J: Malignant epithelioid angiomyolipoma of the kidney.
J Formos Med Assoc. 106 2 Suppl:S51–S54. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kavaney PB and Fielding I: Angiomyolipoma
and renal cell carcinoma in same kidney. Urology. 6:643–646. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Corsenca A, Aebersold F, Moch H, Bird P,
Weber M, Hofbauer G, Wüthrich RP and Serra AL: Combined nephrectomy
and pre-emptive renal transplantation in a tuberous sclerosis
patient with angiomyolipoma, renal carcinoma and life-threatening
abdominal haemorrhages. Nephrol Dial Transplant. 22:3330–3333.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eble JN: Angiomyolipoma of kidney. Semin
Diagn Pathol. 15:21–40. 1998.PubMed/NCBI
|
|
34
|
Cichocki M, Sosnowski M and Jablonowski Z:
A giant renal angiomyolipoma (AML) in a patient with septo-optic
dysplasia (SOD). Eur J Med Res. 19:462014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hussain M, Mubarak M, Sultan G, Sultan G,
Ahmed E, Yunus M, Salehi MA, Asif M, Naqvi Anwer SA and Rizvi SA:
Renal transplant in a tuberous sclerosis patient with bilateral
giant renal angiomyolipomas and concurrent renal carcinoma. Saudi J
Kidney Dis Transpl. 24:318–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Taneja R and Singh DV: Giant renal
angiomyolipoma: Unusual cause of huge abdominal mass. J Clin
Imaging Sci. 3:562013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miyoshi Y, Iwao K, Nawa G, Yoshikawa H,
Ochi T and Nakamura Y: Frequent mutations in the beta-catenin gene
in desmoid tumors from patients without familial adenomatous
polyposis. Oncol Res. 10:591–594. 1998.PubMed/NCBI
|
|
38
|
Yamakado K, Tanaka N, Nakagawa T,
Kobayashi S, Yanagawa M and Takeda K: Renal angiomyolipoma:
Relationships between tumor size, aneurysm formation, and rupture.
Radiology. 225:78–82. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mitra A, Jain Kumar S, Gupta D and Chandra
Murthy Kaza R: Giant angiomyolipoma of the kidney presenting as
anaemia-a rare presentation. Open J Urol. 2:75–77. 2012. View Article : Google Scholar
|
|
40
|
Curatolo P, Bombardieri R and Jozwiak S:
Tuberous sclerosis. Lancet. 372:657–668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang G, Yang L, Yang X, Shi X, Wang J, Liu
Y, Ju J and Zou L: Efficacy and safety of a mammalian target of
rapamycin inhibitor in pediatric patients with tuberous sclerosis
complex: A systematic review and meta-analysis. Exp Ther Med.
9:626–630. 2015.PubMed/NCBI
|
|
42
|
Bissler JJ, McCormack FX, Young LR, Elwing
JM, Chuck G, Leonard JM, Schmithorst VJ, Laor T, Brody AS, Bean J,
et al: Sirolimus for angiomyolipoma in tuberous sclerosis complex
or lymphangioleiomyomatosis. N Engl J Med. 358:140–151. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cabrera-López C, Martí T, Catalá V, Torres
F, Mateu S, Ballarín J and Torra R: Assessing the effectiveness of
rapamycin on angiomyolipoma in tuberous sclerosis: A two years
trial. Orphanet J Rare Dis. 7:872012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Peng ZF, Yang L, Wang TT, Han P, Liu ZH
and Wei Q: Efficacy and safety of sirolimus for renal
angiomyolipoma in patients with tuberous sclerosis complex or
sporadic lymphangioleiomyomatosis: A systematic review. J Urol.
192:1424–1430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Paul E and Thiele E: Efficacy of sirolimus
in treating tuberous sclerosis and lymphangioleiomyomatosis. N Engl
J Med. 358:190–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
